Xu Jiang
- Molecular Biology top 5%
- Cancer Research top 5%
- Immunology top 10%
- Oncology
- Genetics
- Co-authors
- Takashi OkamotoToshifumi TetsukaXiaojie LuNaoko TakahashiNobuo MatsuiXingjie RenLuping LiuJian‐Quan Ni
- Topics
- Parkinson's Disease Mechanisms and Treatments (10 papers)Neurological disorders and treatments (10 papers)MicroRNA in disease regulation (7 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryNature Communications
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Xu Jiang
58 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Biology 1.4k
- Cancer Research 561
- Immunology 289
- Oncology 212
- Genetics 171
Countries citing papers authored by Xu Jiang
This map shows the geographic impact of Xu Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu Jiang more than expected).
Fields of papers citing papers by Xu Jiang
This network shows the impact of papers produced by Xu Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu Jiang. The network helps show where Xu Jiang may publish in the future.
Co-authorship network of co-authors of Xu Jiang
This figure shows the co-authorship network connecting the top 25 collaborators of Xu Jiang. A scholar is included among the top collaborators of Xu Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu Jiang. Xu Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | Inflammatory markers link triglyceride-glucose index and obesity indicators with adverse cardiovascular events in patients with hypertension: insights from three cohortsbreakdown → | 32 |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 11 | |
| 6 | 0 | |
| 7 | 4 | |
| 8 | 3 | |
| 9 | 6 | |
| 10 | 20 | |
| 11 | 1 | |
| 12 | 8 | |
| 13 | 71 | |
| 14 | 29 | |
| 15 | 27 | |
| 16 | 229 | |
| 17 | Rab11 maintains connections between germline stem cells and niche cells in the Drosophila ovary | 3 |
| 18 | 28 | |
| 19 | 156 | |
| 20 | 54 |
About Xu Jiang
Xu Jiang is a scholar working on Aging, Cancer Research and Neurology, having authored 59 papers that have together received 2.1k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (10 papers), Neurological disorders and treatments (10 papers) and MicroRNA in disease regulation (7 papers). The work is most often cited by research in Aging (118 citations), Cancer Research (561 citations) and Molecular Biology (1.4k citations). Xu Jiang has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Takashi Okamoto, Toshifumi Tetsuka, Xiaojie Lu, Naoko Takahashi, Nobuo Matsui, Xingjie Ren, Luping Liu, Jian‐Quan Ni, Zhihao Yang and Jin Sun. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.